Careers  |  Sign In  |  Register

Latest in Rheumatology

A new article in The New York Times reports “A chemical once used to treat sofas — until it was found to cause rashes and blisters in people who sat on them — is now poised to become a major therapy for multiple sclerosis [MS].” The drug, called Tecfidera, was approved by the FDA for treatment of...
Patients with rheumatoid arthritis and other inflammatory diseases are at increased risk for developing infections like shingles. Many of these patients take immunosuppressive drugs to treat the inflammation and pain associated with those diseases. A new study examined whether patients beginning anti-T-N-F...
A new study in Science reveals evidence that “early-life microbial exposures determine sex hormone levels and modify progression to autoimmunity in the nonobese diabetic (NOD) mouse model of type 1 diabetes (T1D).” NOD males were protected from T1D due to elevated serum testosterone prior to colonization...